Status:
UNKNOWN
Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing
Lead Sponsor:
CareDx
Conditions:
Cardiac Transplant Failure
Cardiac Transplant Rejection
Eligibility:
All Genders
15+ years
Brief Summary
The objective of this registry is to observe short and long term clinical outcomes in heart transplant recipients who receive regular AlloMap testing as part of allograft rejection surveillance.
Detailed Description
The standard of care in adult heart transplant recipients has been to perform periodic endomyocardial biopsies for surveillance for rejection. Because of the risks and discomforts associated with the ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- New and existing heart transplant recipients ≥ 2 months (≥ 55 days) post-transplant receiving post-transplant care at the enrolling centers for interim surveillance monitoring that includes AlloMap testing
Exclusion
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
2444 Patients enrolled
Trial Details
Trial ID
NCT01833195
Start Date
March 1 2013
End Date
February 1 2020
Last Update
February 5 2020
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Phoenix, Arizona, United States, 85054
2
Cedars-Sinai Medical Center
Beverly Hills, California, United States, 90211
3
University of California, Los Angeles
Los Angeles, California, United States, 90095
4
Stanford University
Stanford, California, United States, 94305